SEC EDGAR CompanyFacts fact · reporting period
ONYX PHARMACEUTICALS INC: cashflow_operating
One fact, its scope and the complete path back to the official record.
Reported value
$28.357M{"amount": 28357000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "currency": "USD"}- Entity
- ONYX PHARMACEUTICALS INC
- Metric
- cashflow_operating
- Period
- 2010-01-01 – 2010-12-31
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-08-19T09:49:48.184497+02:00
Raw response SHA-256
f7bde1a401b286c74a2fd824ee1df541…Official-identifier path
https://factanker.com/fact/sec/cik-0001012140/cashflow-operating/2010-12-31 (CIK, metric, reporting date)History
- supersedes {"amount": 28357000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} (evidence 0000950123-11-017166)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.